Abstract Details

Title Clinical and histopathological findings in myotonic muscular dystrophy type 2 (DM2): retrospective review of 49 DNA-confirmed cases

Topic Neuromuscular and Clinical Neurophysiology (EMG)

Presentation(s) P1 - (-)

Poster/Presentation
Number 124

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Bhaskar Roy, MD, FAAN (Yale University) PRESENTER	Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Roy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Roy has stock in Cabaletta bio. . Dr. Roy has stock in Pfizer. Dr. Roy has stock in CAVA. The institution of Dr. Roy has received research support from Abcuro Pharmaceuticals. The institution of Dr. Roy has received research support from Immunovant. The institution of Dr. Roy has received research support from argenx.
	No disclosure on file
Charles H. Whitaker, MD (Hospital for Special Care)	No disclosure on file
Kevin Felice, DO (Hospital for Special Care)	No disclosure on file

��ɫ��